Status:
NOT_YET_RECRUITING
A Prospective Study Using SupraSDRM® in Promoting Healing and Reducing the Time to Grafting of Full-thickness Wounds
Lead Sponsor:
The Metis Foundation
Collaborating Sponsors:
The University of Texas Medical Branch, Galveston
United States Department of Defense
Conditions:
Surgical Wound
Burns
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This is a prospective, randomized, controlled, multi-center clinical study comparing SupraSDRM® to standard of care wound dressing, BTM, in the treatment of full-thickness wounds deemed not immediatel...
Detailed Description
Twenty-four patients with full-thickness wounds fulfilling inclusion criteria of the study will be consented and enrolled into the clinical trial. An area (≥ 5 and ≤125 cm2) deemed not immediately rea...
Eligibility Criteria
Inclusion
- Patient age ≥18 years and ≤85 years
- Full-thickness traumatic injury, surgical wound, or excised full-thickness burn (e.g., friction, contact, flame, scalding etiology), where immediate grafting is not deemed suitable by the treating surgeon
- Wound size ≥ 5cm2 not immediately suitable for graft application
- Subject or legally authorized representative is able and willing to sign informed consent
Exclusion
- Study wound may not include areas of the face, and neck and genitalia.
- Wound with metal hardware exposure
- Pressure sores
- Wounds with residual malignancy
- Wound infection at the time of planned wound dressing application
- Wound that is a part of an active treatment arm of an interventional study (within 90 days of Screening Visit)
- Pregnancy/lactation
- Subjects who are unable to follow the protocol or who are likely to be non-compliant
- Subjects with uncontrolled diabetes (defined by Hgb A1C \>10)
- Subjects who are receiving systemic steroids or immune suppressive treatment
- Subject with a known allergy to polylactide, polycaprolactone, polyvinyl alcohol, trimethylene carbonate or resorbable suture materials.
- Prisoners
Key Trial Info
Start Date :
March 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06503406
Start Date
March 1 2025
End Date
October 1 2026
Last Update
February 21 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.